


Wada testing, also known as the intracarotid amobarbital procedure, is a specialized diagnostic test used in the evaluation of patients with epilepsy who may be candidates for epilepsy surgery. The test helps determine which side of the brain is responsible for language and memory functions, allowing physicians to assess surgical risk and preserve critical neurological abilities.
Wada testing may be recommended for patients who:
Wada testing is performed in a controlled clinical setting under careful monitoring. A catheter is guided through an artery to deliver a short-acting medication to one side of the brain at a time, temporarily putting that hemisphere to sleep. While one side is inactive, patients complete language and memory tasks administered by a trained neuropsychology team. The process is then repeated on the opposite side of the brain.

